Keswani Sanjay Chandru — SEC insider filings
SEC reporting owner CIK 1818524. 7 insider filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2021-03-01 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,995 shares, $120,512 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 3,995 shares @ $30.17 ($120,512) in Annexon, Inc., filed 2021-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | EVP & Chief Medical Officer | 3 | — | 1 leg · 3,995 sh · $120,512 | 5 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | 4 | — | — | 9 |
Insider filings — Keswani Sanjay Chandru
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 3,914 @ $0 · Tax withholding (F): 2,112 @ $156.22 | EDGAR |
| 2026-06-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,212 @ $0 · Tax withholding (F): 1,733 @ $154.84 · Option exercise (M): 3,212 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 35,827 (derivative) @ $0 · Grant/award (A): 6,285 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 12,846 (derivative) @ $0 · Grant/award (A): 70,101 (derivative) @ $0 | EDGAR |
| 2022-02-15 | 4 | Annexon, Inc. (ANNX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-03-26 | 4 | Annexon, Inc. (ANNX) | Option exercise (M): 3,995 @ $7.49 · Sale (S): 3,995 @ $30.17 · Option exercise (M): 3,995 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | Annexon, Inc. (ANNX) | Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1818524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs